Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jun 7, 2022

50715_rns_2022-06-07_63f48889-e564-4b7b-8dea-5afe18124ae3.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

7 June 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

PartyChina InternationalCapital CorporationLimited Date6 June2022 Descriptionof relevantsecuritiesOrdinaryshares Nature of dealingsDisposal of the underlying sharesreceived from the redemption ofpre-existing index-tracking ETFsas a result of unsolicited clientrequests Purchase/ SaleSale Totalnumber ofsharesinvolved20,000 Total amountpaid / received$785,855.0000 Highest (H)prices paid/ received$39.4200 Lowest (L)prices paid/ received$39.2400

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.